MARY NORTON: Open Payments
NPI 1255411849 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 4 | $67 |
| SCPHARMACEUTICALS INC. | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Baxter Healthcare | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| CVRx, Inc. | 1 | $14 |
Products named: Attruby, FUROSCIX, LEQVIO, WAINUA, Hillrom - Carnation Ambulatory Monitor, Kerendia, EVKEEZA, Barostim Neo System.
Industry payments across NY — which companies pay providers there.
